MPPE1 and infection: Many preclinical studies in various mouse models have demonstrated the efficacy of in vivo targeting of Ag specifically to cDC1 in combination with the administration of a proper adjuvant for priming or reactivating adaptive immunity, leading to a rapid yet long term immune protection against infections by intracellular pathogens or against tumors (119) (Table S1).